IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and Adults
Clinical trial NCT03092791 · TERMINATED
Trial details
- NCT number
- NCT03092791
- Sponsor
- Takeda
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-07
- Primary completion
- 2018-04-03
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.